Foresee Home Sets New Standard of Care for AMD Patients

by Dan Roberts Updated 3/1/2016 A relatively new technology, called preferential hyperacuity perimetry (PHP) allows eye doctors to detect progression in AMD sooner than with the Amsler grid. The key to the best outcome for treatment of wet AMD is early diagnosis and treatment. The ForeseeHomeª AMD Monitor by Notal Vision is approved by the [Read More]

Brachytherapy May Reduce Burden of Treatment and Further Improve Visual Acuity

(Updated August 26, 2020) San Francisco, CA (PRWEB) October 27, 2009 — NeoVista, Inc. made public at the American Academy of Ophthalmology meeting the company’s interim study results from the preliminary study MERITAGE-I. The study was designed to examine the company’s novel epimacular brachytherapy procedure when used in patients that require chronic anti-VEGF treatment for [Read More]

Echothiophate (ECHO) Therapy Causes a Stir in the Low Vision Community

by Dan Roberts November 2003 (Updated January 29, 2009) A Connecticut ophthalmologist has been reporting success from a deceptively simple treatment on patients with Stargardt’s disease and other non-neovascular forms of retinal disease. Dr. Gerard Michael Nolan has performed the treatment, called ECHO therapy, for nearly three years on more than 200 patients at the [Read More]

Intraocular Injections and Eye Pain

by Dan Roberts November 2006 Some people have been reporting considerable pain and/or conjunctival hemorrhaging (eye redness) following intraocular injections of anti-angiogenic drugs (Macugen, Lucentis and off-label Avastin) for wet AMD. Most patients, however, are reporting nothing more than some discomfort. The following information has been gathered from patients who have undergone the procedure. In [Read More]

Drusen Lasering

by Dan Roberts (Updated 11/4/06) Drusen are thought to be fatty waste products from the photoreceptor cells. They often appear on the macula (the center of the retina) in the early stages of Macular Degeneration, and they can cause gradual loss of central vision. “Hard” drusen are common in aging eyes, and do not necessarily [Read More]